Earnings History Data for AN2 Therapeutics, Inc. (ANTX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
AN2 Therapeutics, Inc.
AN2 Therapeutics Inc. is a clinical-stage biopharmaceutical company. It focused on developing treatments for rare, chronic and serious infectious diseases with high unmet needs. AN2 Therapeutics Inc. is based in MENLO PARK, Calif.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13-08-2024 | PM | ANTX | AN2 Therapeutics | 31.00 | -0.48 | -0.63 | 0.00 | AN2 Therapeutics GAAP EPS of -$0.48 [8/14/2024 9:50 AM] |
1.04 | -0.05 (-4.13%) |
1.06 | -0.03 (-2.74%) |
0.87 - 22.22 | 2,159,834 | 1,600,000 | 10,722 | ||
| 14-05-2024 | AH | ANTX | AN2 Therapeutics | 72.00 | -0.56 | -0.61 | 0.00 | AN2 Therapeutics reports Q1 results [5/15/2024 10:42 AM] |
2.26 | -0.05 (-2.16%) |
2.38 | 0.07 (3.03%) |
2.20 - 22.22 | 225,321 | 90,000 | 10,013 | ||
| 28-03-2024 | PM | ANTX | AN2 Therapeutics | 93.00 | -0.57 | -0.71 | 0.00 | AN2 Therapeutics GAAP EPS of -$0.57 beats by $0.17 [3/29/2024 6:57 AM] |
3.25 | 0.03 (0.93%) |
3.25 | 0.0 (0.00%) |
2.72 - 22.22 | 333,955 | 360,000 | 66,860 | ||
| 11-05-2023 | AH | 4:05 PM ET (May 11) |
ANTX | AN2 Therapeutics | 100.00 | -0.79 | -0.68 | 0.00 | AN2 Therapeutics GAAP EPS of -$0.79 [5/11/2023 5:47 PM] |
5.20 | 0.14 (2.77%) |
5.06 | 0.0 (0.00%) |
4.87 - 23.58 | 54,347 | 40,000 | 1,040 | |
| 09-11-2022 | AH | ANTX | AN2 Therapeutics | 329.00 | -0.59 | -0.59 | 0.00 | AN2 Therapeutics GAAP EPS of -$0.59 in-line [11/9/2022 5:41 PM] |
14.65 | -1.23 (-7.71%) |
0.0 | 0.0 (0.00%) |
6.88 - 23.58 | 54,521 | 30,000 | 0 | ||
| 11-08-2022 | AH | After the close (Aug 11) |
ANTX | AN2 Therapeutics | 219.00 | -0.53 | -0.45 | 0.00 | AN2 Therapeutics GAAP EPS of -$0.53 beats by $1.36 [8/11/2022 5:18 PM] |
19.32 | 7.55 (64.15%) |
11.77 | 0.0 (0.00%) |
6.88 - 23.58 | 228,771 | 20,000 | 209 | |